FMA
ARRY

FNY Managed Accounts’s Array Biopharma Inc ARRY Stock Holding History

FNY Managed Accounts’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$2K Buy
+174
New +$2.79K ﹤0.01% 469
2017
Q2 		– Sell
-750
Closed -$6K – 758
2017
Q1 		$6K Buy
+750
New +$7.98K 0.02% 607

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FNY Managed Accounts's ARRY Position: Q1 2018 in Review

FNY Managed Accounts opened a new position in Array Biopharma Inc (ARRY) in Q1 2018: 174 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #469 among its holdings. This is a return to the name: FNY Managed Accounts previously reported a position in ARRY as recently as Q1 2017.

FNY Managed Accounts first reported a position in ARRY in Q1 2017 and has held it in 2 quarters since. The position peaked at $6K in Q1 2017. 235 funds tracked by Wall St. Rank hold ARRY as of Q1 2018.

  • FNY Managed Accounts held 174 shares of Array Biopharma Inc worth $2K as of Q1 2018.
  • Array Biopharma Inc was a new FNY Managed Accounts position in Q1 2018.
  • Array Biopharma Inc made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #469 holding.
  • FNY Managed Accounts first reported a position in Array Biopharma Inc in Q1 2017 and has held it in 2 quarters since.
  • FNY Managed Accounts's Array Biopharma Inc position peaked at $6K in Q1 2017.
  • 235 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.